A carregar...

Modeling Adaptive Resistance of KRAS Mutant Colorectal Cancer to MAPK Pathway Inhibitors with a Three-Dimensional Tumor Model

[Image: see text] Single-agent drug treatment of KRAS(mut) colorectal cancers is often ineffective because the activation of compensatory signaling pathways leads to drug resistance. To mimic cyclic chemotherapy treatments of patients, we showed that intermittent treatments of 3D tumor spheroids of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Pharmacol Transl Sci
Main Authors: Shahi Thakuri, Pradip, Lamichhane, Astha, Singh, Sunil, Gupta, Megha, Luker, Gary D., Tavana, Hossein
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2020
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737205/
https://ncbi.nlm.nih.gov/pubmed/33344895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!